# US 11,998,655 B2 · Collagen biomaterials and methods for manufacturing collagen biomaterials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,998,655 B2
- Document ID: US11998655B2
- Status: Granted
- Kind: B2
- Application number: 17/056,391
- Filed: 2019-05-17
- Published: 2021-06-24
- Granted: 2024-06-04
- Earliest claimed: 2018-05-18
- Assignees: Cambridge Enterprise Limited
- Applicants: Cambridge Enterprise Limited
- Inventors: Ruth Elizabeth Cameron; Serena Michelle Best; David James Barrett; Matthew Linley
- Web page: https://patentgrep.com/patent/US11998655B2

## CPC

- A61L 24/001: {Use of materials characterised by their function or physical properties}
- A61L 24/102: {Collagen}
- A61L 24/0015: {Medicaments; Biocides}
- A61L 27/24: Collagen
- A61L 27/34: Macromolecular materials
- A61L 27/38: {containing added animal cells (organs or tissue containing native cells A61L27/36)}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/507: {for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062)}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 2420/08: Coatings comprising two or more layers
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

This invention relates to collagen biomaterials and methods for manufacturing collagen biomaterials. Method disclosed herein include steps of providing a suspension of insoluble collagen fibres, providing a layer deposition interface and applying an electric field across the suspension to cause electrophoretic deposition of the insoluble collagen fibres at the layer deposition interface. Biomaterials disclosed herein include a layer comprising an array of fibres of collagen, and a layered composite material comprising at least first and second fibrous layers each comprising an array of fibres of collagen, and a shape adapting layer sandwiched between the first and second fibrous layers. Biomaterials as described herein may be useful in a range of tissue engineering and other applications.

## Claims

### Claim 1

A method of manufacturing a layer comprising an array of fibres of collagen, the method comprising:
providing a suspension of insoluble collagen fibres;
providing a layer deposition interface;
applying an electric field across the suspension to cause electrophoretic deposition of the insoluble collagen fibres at the layer deposition interface, thereby building up a layer comprising deposited collagen,
wherein the electric field is pulsed in order to subject the suspension to pulsed electrophoresis, the electric field strength being in the range 100-2000V/m, the average pulse length being in the range 10-100 ms and a duty cycle being 20-70%, and wherein the method further comprises causing relative movement, in a relative movement direction, between the layer deposition interface and the suspension, thereby causing alignment of the collagen fibres in the layer, the fibres being substantially aligned within the layer along a first in-plane direction substantially parallel to the relative movement direction.

### Claim 2 (depends on 1)

The method according to claim 1 wherein the duty cycle is 30-60%.

### Claim 3 (depends on 1)

The method according to claim 1 wherein the electric field is applied between opposing electrodes, the potential difference between the electrodes being at most 20 V.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the electric field is applied between, opposing electrodes, wherein at least one of the opposing electrodes in is contact with the suspension, a surface of the electrode providing the layer deposition interface.

### Claim 5 (depends on 1)

The method according to claim 1, the method further comprising lyophilising the layer comprising an array of fibres of collagen.

### Claim 6 (depends on 1)

The method according to claim 1, the method further comprising steps of drying the layer comprising an array of fibres of collagen to form a collagen membrane, disposing the collagen membrane within a mould, at least partially filling the mould with a suspension of insoluble collagen fibres, and lyophilising of the mould containing the suspension of insoluble collagen fibres and the collagen membrane to thereby form a porous collagen scaffold incorporating the collagen membrane.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the suspension of insoluble collagen fibres further comprises viable mammalian cells, such that the cells are embedded in the layer during the electrophoretic deposition of the insoluble collagen fibres.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the layer deposition interface comprises a surface of a release layer.

### Claim 9 (depends on 1)

The method according to claim 1 wherein the suspension of insoluble collagen fibres further comprises one or more therapeutic compounds, such that the one or more therapeutic compounds are comprised in the layer during the electrophoretic deposition of the insoluble collagen fibres.

### Claim 10 (depends on 1)

The method according to claim 1 wherein, after deposition of the layer comprising deposited collagen, the relative movement direction is changed, in order to deposit a subsequent layer in which the fibres are substantially aligned within the layer along a second in-plane direction, not parallel with the first in-plane direction.

### Claim 11

A method of manufacturing a layer comprising an array of fibres of collagen, the method comprising:
providing a suspension of insoluble collagen fibres;
providing a layer deposition interface;
applying an electric field across the suspension to cause electrophoretic deposition of the insoluble collagen fibres at the layer deposition interface, thereby building up a layer comprising deposited collagen,
wherein the layer deposition interface is provided by a membrane or scaffold having opposing major surfaces, the membrane or scaffold being supported by the suspension by at least one of the major surfaces of the membrane or scaffold being in contact with the suspension, and wherein the method further comprises causing relative movement, in a relative movement direction, between the layer deposition interface and the suspension, thereby causing alignment of the collagen fibres in the layer, the fibres being substantially aligned within the layer along a first in-plane direction substantially parallel to the relative movement direction.

### Claim 12 (depends on 11)

The method according to claim 11 wherein the layer deposition interface is provided by a collagen membrane and the collagen membrane is held within the suspension with both of the major surfaces of the membrane being in contact with the suspension.

### Claim 13 (depends on 11)

The method according to claim 11, the method further comprising lyophilising the layer comprising an array of fibres of collagen.

### Claim 14 (depends on 11)

The method according to claim 11, the method further comprising steps of drying the layer comprising an array of fibres of collagen to form a collagen membrane, disposing the collagen membrane within a mould, at least partially filling the mould with a suspension of insoluble collagen fibres, and lyophilising of the mould containing the suspension of insoluble collagen fibres and the collagen membrane to thereby form a porous collagen scaffold incorporating the collagen membrane.

### Claim 15 (depends on 11)

The method according to claim 11, wherein the suspension of insoluble collagen fibres further comprises viable mammalian cells, such that the cells are embedded in the layer during the electrophoretic deposition of the insoluble collagen fibres.

### Claim 16 (depends on 11)

The method according to claim 11, wherein the layer deposition interface comprises a surface of a release layer.

### Claim 17 (depends on 11)

The method according to claim 11 wherein the suspension of insoluble collagen fibres further comprises one or more therapeutic compounds, such that the one or more therapeutic compounds are comprised in the layer during the electrophoretic deposition of the insoluble collagen fibres.

### Claim 18 (depends on 11)

The method according to claim 11 wherein, after deposition of the layer comprising deposited collagen, the relative movement direction is changed, in order to deposit a subsequent layer in which the fibres are substantially aligned within the layer along a second in-plane direction, not parallel with the first in-plane direction.
